Skip to main content

Table 2 Change in airway reactivity

From: A pilot randomized controlled trial of pioglitazone for the treatment of poorly controlled asthma in obesity

 

placebo

pioglitazone

P-value*

PC20 at baseline (mg/ml)

1.99 (3.08)

1.60 (5.91)

 

n = 11

n = 12

 

PC20 at 12 weeks (mg/ml)

2.37 (15.22)

5.08 (7.42)

 

n = 9

n = 10

0.38

  1. Values shown are median and IQR
  2. *P-value shown for mixed model repeated measures analysis of variance, treatment by time interaction